77 related articles for article (PubMed ID: 38612833)
1. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers.
Marchal C; Weber B; de Lafontan B; Resbeut M; Mignotte H; du Chatelard PP; Cutuli B; Reme-Saumon M; Broussier-Leroux A; Chaplain G; Lesaunier F; Dilhuydy JM; Lagrange JL
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):113-9. PubMed ID: 10219803
[TBL] [Abstract][Full Text] [Related]
2. Treatment Monitoring of a Patient with Synchronous Metastatic Angiosarcoma and Breast Cancer Using ctDNA.
Vannas C; Escobar M; Österlund T; Andersson D; Mouhanna P; Soomägi A; Molin C; Wennergren D; Fagman H; Ståhlberg A
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612833
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Molecular Insights of Radiation-Induced Breast Sarcomas: Is There Hope on the Horizon for Effective Treatment of This Aggressive Disease?
Kokkali S; Moreno JD; Klijanienko J; Theocharis S
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456944
[TBL] [Abstract][Full Text] [Related]
4. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
Pereira E; Camacho-Vanegas O; Anand S; Sebra R; Catalina Camacho S; Garnar-Wortzel L; Nair N; Moshier E; Wooten M; Uzilov A; Chen R; Prasad-Hayes M; Zakashansky K; Beddoe AM; Schadt E; Dottino P; Martignetti JA
PLoS One; 2015; 10(12):e0145754. PubMed ID: 26717006
[TBL] [Abstract][Full Text] [Related]
5. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.
Painter CA; Jain E; Tomson BN; Dunphy M; Stoddard RE; Thomas BS; Damon AL; Shah S; Kim D; Gómez Tejeda Zañudo J; Hornick JL; Chen YL; Merriam P; Raut CP; Demetri GD; Van Tine BA; Lander ES; Golub TR; Wagle N
Nat Med; 2020 Feb; 26(2):181-187. PubMed ID: 32042194
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study.
Yin M; Wang W; Drabick JJ; Harold HA
BMC Cancer; 2017 Apr; 17(1):295. PubMed ID: 28449661
[TBL] [Abstract][Full Text] [Related]
7. Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study.
Veiga LHS; Vo JB; Curtis RE; Mille MM; Lee C; Ramin C; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Lancet Oncol; 2022 Nov; 23(11):1451-1464. PubMed ID: 36240805
[TBL] [Abstract][Full Text] [Related]
8. Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes.
Fridlich O; Peretz A; Fox-Fisher I; Pyanzin S; Dadon Z; Shcolnik E; Sadeh R; Fialkoff G; Sharkia I; Moss J; Arpinati L; Nice S; Nogiec CD; Ahuno ST; Li R; Taborda E; Dunkelbarger S; Fridlender ZG; Polak P; Kaplan T; Friedman N; Glaser B; Shemer R; Constantini N; Dor Y
Cell Rep Med; 2023 Jun; 4(6):101074. PubMed ID: 37290439
[TBL] [Abstract][Full Text] [Related]
9. The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Guven DC; Sahin TK; Erul E; Rizzo A; Ricci AD; Aksoy S; Yalcin S
Front Mol Biosci; 2022; 9():1039121. PubMed ID: 36533070
[No Abstract] [Full Text] [Related]
10. Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer.
Barnell EK; Fisk B; Skidmore ZL; Cotto KC; Basu A; Anand A; Richters MM; Luo J; Fronick C; Anurag M; Fulton R; Ellis MJ; Griffith OL; Griffith M; Ademuyiwa FO
Sci Rep; 2022 Oct; 12(1):17732. PubMed ID: 36273232
[TBL] [Abstract][Full Text] [Related]
11. UMIErrorCorrect and UMIAnalyzer: Software for Consensus Read Generation, Error Correction, and Visualization Using Unique Molecular Identifiers.
Österlund T; Filges S; Johansson G; Ståhlberg A
Clin Chem; 2022 Nov; 68(11):1425-1435. PubMed ID: 36031761
[TBL] [Abstract][Full Text] [Related]
12. Plasma cfDNA predictors of established bacteraemic infection.
Urosevic N; Merritt AJ; Inglis TJJ
Access Microbiol; 2022 Aug; 4(6):acmi000373. PubMed ID: 36004363
[No Abstract] [Full Text] [Related]
13. Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.
Zhou Q; Gampenrieder SP; Frantal S; Rinnerthaler G; Singer CF; Egle D; Pfeiler G; Bartsch R; Wette V; Pichler A; Petru E; Dubsky PC; Bago-Horvath Z; Fesl C; Rudas M; Ståhlberg A; Graf R; Weber S; Dandachi N; Filipits M; Gnant M; Balic M; Heitzer E
Clin Cancer Res; 2022 Feb; 28(4):697-707. PubMed ID: 34862246
[TBL] [Abstract][Full Text] [Related]
14. dPCR application in liquid biopsies: divide and conquer.
Moreno-Manuel A; Calabuig-Fariñas S; Obrador-Hevia A; Blasco A; Fernández-Díaz A; Sirera R; Camps C; Jantus-Lewintre E
Expert Rev Mol Diagn; 2021 Jan; 21(1):3-15. PubMed ID: 33305634
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]